Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy C Jones

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Vaccines|November 19, 2020
Antibody Responses to SARS-CoV-2 Antigens in Humans and AnimalsHyunsuh Kim, Patrick Seiler, Jeremy C Jones, et al.
European Journal of Medicinal Chemistry|January 5, 2023
Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potentialPeter J Slavish, Maxime G Cuypers, Mary Ashley Rimmer, et al.
International Journal of Particle Therapy|February 1, 2023
Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival OutcomesMichael S Rutenberg, Bradford S Hoppe, Jason S Starr, et al.
JCO Precision Oncology|March 25, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal CarcinomaFares Jamal, Oudai Sahwan, Seyi Abidoye, et al.
The Journal of Antimicrobial Chemotherapy|December 28, 2020
Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavirAndrei A Ivashchenko, Oleg D Mitkin, Jeremy C Jones, et al.
Nature Communications|July 22, 2025
Genotype B3.13 influenza A(H5N1) viruses isolated from dairy cattle demonstrate high virulence in laboratory models, but retain avian virus-like propertiesThomas P Fabrizio, Ahmed Kandeil, Walter N Harrington, et al.
Cureus|May 14, 2023
Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology ProgramJeremy C Jones, Michael A Golafshar, Tucker W Coston, et al.
Communications Biology|April 18, 2024
Highly pathogenic avian influenza A(H5N1) virus in a common bottlenose dolphin (Tursiops truncatus) in FloridaAllison Murawski, Thomas Fabrizio, Robert Ossiboff, et al.
Emerging Microbes & Infections|March 23, 2021
Antigenic and molecular characterization of low pathogenic avian influenza A(H9N2) viruses in sub-Saharan Africa from 2017 through 2019Maxime Fusade-Boyer, Fidélia Djegui, Komla Batawui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2017
<sup>Non-V600</sup> BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal CancerJeremy C Jones, Lindsay A Renfro, Humaid O Al-Shamsi, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Vaccines|November 19, 2020
Antibody Responses to SARS-CoV-2 Antigens in Humans and AnimalsHyunsuh Kim, Patrick Seiler, Jeremy C Jones, et al.
European Journal of Medicinal Chemistry|January 5, 2023
Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potentialPeter J Slavish, Maxime G Cuypers, Mary Ashley Rimmer, et al.
International Journal of Particle Therapy|February 1, 2023
Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival OutcomesMichael S Rutenberg, Bradford S Hoppe, Jason S Starr, et al.
JCO Precision Oncology|March 25, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal CarcinomaFares Jamal, Oudai Sahwan, Seyi Abidoye, et al.
The Journal of Antimicrobial Chemotherapy|December 28, 2020
Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavirAndrei A Ivashchenko, Oleg D Mitkin, Jeremy C Jones, et al.
Nature Communications|July 22, 2025
Genotype B3.13 influenza A(H5N1) viruses isolated from dairy cattle demonstrate high virulence in laboratory models, but retain avian virus-like propertiesThomas P Fabrizio, Ahmed Kandeil, Walter N Harrington, et al.
Cureus|May 14, 2023
Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology ProgramJeremy C Jones, Michael A Golafshar, Tucker W Coston, et al.
Communications Biology|April 18, 2024
Highly pathogenic avian influenza A(H5N1) virus in a common bottlenose dolphin (Tursiops truncatus) in FloridaAllison Murawski, Thomas Fabrizio, Robert Ossiboff, et al.
Emerging Microbes & Infections|March 23, 2021
Antigenic and molecular characterization of low pathogenic avian influenza A(H9N2) viruses in sub-Saharan Africa from 2017 through 2019Maxime Fusade-Boyer, Fidélia Djegui, Komla Batawui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2017
<sup>Non-V600</sup> BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal CancerJeremy C Jones, Lindsay A Renfro, Humaid O Al-Shamsi, et al.
Pageof 8